Furthermore, TKI-resistant EGFR-mutant LUADs that have undergone SCLC transformation typically lack the acquisition of other genetic alterations associated with TKI resistance that are known to reactivate MAPK signaling (Roper et al., 2020). Here, EGFR is linked to small cell lung carcinoma.